Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
72 Leser
Artikel bewerten:
(0)

Stem Cell Cream Store Announces Grand Opening of New Stem Cell Anti Aging Cream / A new stem cell cream company has officially launched their website and is offering a great deal on their cream along with top notch customer service

OVIEDO, Fla., March 20, 2011 /PRNewswire/ -- Stem cell cream technology may be the wave of the future when it comes to anti-wrinkle and anti-aging cosmetics; the newest kid on the block is Bio-Therapie, LLC and they are taking the world of anti-wrinkle cream by storm with their Stem Cell Cream.

"Customer service is one of our biggest points," says Tiffany Ellis of Bio-Therapie, LLC. "We strive to separate ourselves from other companies that offer big deals, but then hook you onto a repetitive auto-billing cycle. These kinds of things are always buried in the fine print and honestly, I think people are tired of it. They shouldn't have to be searching the fine print on a site for the 'catch.' With us, there isn't one. You get what you order and no surprises later. Just good, honest business."

Indeed auto-billing scams have been around since the invention of infomercials and consumers have learned to be hesitant about any offer that includes the words "free trial." Millions of dollars a year are accidentally spent on scams like this and the truth is, consumers are getting fed up.

"I hate having to skim the fine print every time I'm interested in a product that offers a free trial or a special deal," says Amanda Kay, a customer of Stem Cell Cream Store. "I'm hesitant to buy products that might come with a subscription attached, even if they make it clear that it's a subscription. Explaining that my rent check bounced due to a subscription they didn't honestly sign me up for is really embarrassing."

Not all companies that offer free trials are trying to skim money out of their customer's wallets, but the truth is that auto-billing and subscriptions are often more trouble than they are worth for consumers and lead to losses in potential sales due to the fear of being scammed. In these harsh economic times in the United States, people are steering clear of the free trial offers they would have fallen for in the past.

"We like just doing a straight purchase," says Tiffany. "We don't offer subscriptions or free trials simply because they are associated with companies that use them to deliberately defraud their customers. As it stands right now, people don't have a lot of money to gamble with. We help keep it simple and since we offer a no questions asked 30 day money back, no auto-billing guarantee, there's zero risk in purchasing from us. We keep our promises."

The grand opening special for their Stem Cell Cream is a buy 1 get 1 free offer for $59.95.

Bio-Therapie, LLC is a stem cell cream company located in Oviedo, Florida and is committed to bringing you the best customer service and beauty products currently available on the market.

Website: http://www.stemcellcreamstore.com

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

Bio-Therapie, LLC

CONTACT: Tiffany Ellis for Bio-Therapie, LLC, +1-510-230-3947,
darksgtphoenix@gmail.com

Web site: http://www.stemcellcreamstore.com/
http://www.24-7pressrelease.com/

© 2011 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.